Andrew McClellan is an Ophthalmology physician affiliated with Texas Retina Associates. OpenAlex indexes 34 publications with 706 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9600 N Central Expy Ste 100
Dallas, TX 752315078
Telephone
214-692-6941Registry record last updated 15 Nov 2018.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20244 payments
- Alcon Vision LLCProgram year20241 payment
- Astellas Pharma US IncProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
89.6%Antineovascularisation agents81.4%Faricimab-svoa100%Part B, office-administered≥155 patientsComplement Inhibitor7.4%Avacincaptad pegol100%Part B, office-administered≥58 patients+ 5 more classes in this area
Cancer & immunology
10.2%Complement Inhibitor6.4%Pegcetacoplan100%Part B, office-administered≥53 patientsVascular Endothelial Growth Factor Inhibitor3.8%Aflibercept100%Part B, office-administered≥293 patientsMusculoskeletal
0.1%Cyclooxygenase Inhibitor0.1%Ketorolac Tromethamine100%Part D≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Sall, MD
Texas Retina Associates
Rajiv Anand, MD
Texas Retina Associates
Ashkan Abbey, MD
Texas Retina Associates
Philip Storey, MD
Texas Retina Associates
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”